Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration
Source abstract
Abstract
This study aimed to examine the applicability of polyethyleneimine (PEI)-modified magnetic nanoparticles (GPEI) as a potential vascular drug/gene carrier to brain tumors. In vitro, GPEI exhibited high cell association and low cell toxicity--properties which are highly desirable for intracellular drug/gene delivery. In addition, a high saturation magnetization of 93 emu/g Fe was expected to facilitate magnetic targeting of GPEI to brain tumor lesions. However, following intravenous administration, GPEI could not be magnetically accumulated in tumors of rats harboring orthotopic 9L-gliosarcomas due to its poor pharmacokinetic properties, reflected by a negligibly low plasma AUC of 12 +/- 3 microg Fe/ml min. To improve "passive" GPEI presentation to brain tumor vasculature for subsequent "active" magnetic capture, we examined the intra-carotid route as an alternative for nanoparticle administration. Intra-carotid administration in conjunction with magnetic targeting resulted in 30-fold (p=0.002) increase in tumor entrapment of GPEI compared to that seen with intravenous administration. In addition, magnetic accumulation of cationic GPEI (zeta-potential = + 37.2 mV) in tumor lesions was 5.2-fold higher (p=0.004) than that achieved with slightly anionic G100 (zeta-potential= -12 mV) following intra-carotid administration, while no significant accumulation difference was detected between the two types of nanoparticles in the contra-lateral brain (p=0.187). These promising results warrant further investigation of GPEI as a potential cell-permeable, magnetically-responsive platform for brain tumor delivery of drugs and genes.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (38)
Show source-provided references
1. Malignant gliomas in 2005: where to go from here?10.1001/jama.293.5.615 ↗
2. Potential of gene therapy for brain tumors10.1093/hmg/10.7.777 ↗
3. Chemotherapy of brain tumors: physiological and pharmacokinetic considerations
4. Targeted drug delivery for brain cancer treatment10.1016/S0168-3659(99)00229-1 ↗
5. Brain tumors in children10.1001/archneur.56.4.421 ↗
6. Cognitive functioning and quality of life in malignant glioma patients: a review of the literature10.1002/(SICI)1099-1611(199709)6:3<169::AID-PON269>3.0.CO;2-# ↗
7. The blood–brain and blood–tumor barriers: a review of strategies for increasing drug delivery10.1093/neuonc/2.1.45 ↗
8. Colloidal carriers and blood-brain barrier (bbb) translocation: a way to deliver drugs to the brain?10.1016/j.ijpharm.2005.03.031 ↗
9. Magnetic nanoparticles for drug delivery10.1002/ddr.20067 ↗
10. Locoregional cancer treatment with magnetic drug targeting
11. Preclinical experiences with magnetic drug targeting: tolerance and efficacy
12. Clinical experiences with magnetic drug targeting: A phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors
13. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors10.1016/j.biomaterials.2007.08.050 ↗
14. Polyethyleneimine functionalized iron oxide nanoparticles as agents for DNA delivery and transfection10.1039/b617402g ↗
15. Uptake and metabolism of a dual fluorochrome tat-nanoparticle in hela cells10.1021/bc034123v ↗
16. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors
17. Distribution of anionic sites on the capillary endothelium in an experimental brain-tumor model
18. Colloidal magnetic-resonance contrast agents – effect of particle surface on biodistribution10.1016/0304-8853(93)91115-N ↗
19. A critical evaluation of the principles governing the advantages of intra-arterial infusions10.1007/BF01059765 ↗
20. Distribution of radiolabeled 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride in rat-brain tumor - intraarterial versus intravenous administration
21. Intra-arterial chemotherapy of malignant gliomas
22. Synthesis and biomedical applications of functionalized fluorescent and magnetic dual reporter nanoparticles as obtained in the miniemulsion process10.1088/0953-8984/18/38/S04 ↗
23. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides10.1016/0003-2697(70)90146-6 ↗
24. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays10.1016/0022-1759(83)90303-4 ↗
25. Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study10.1073/pnas.95.12.7012 ↗
26. An improved method for carotid-artery infusion without vessel occlusion10.1016/0031-9384(92)90485-K ↗
27. Comparison of electron spin resonance spectroscopy and inductively-coupled plasma optical emission spectroscopy for biodistribution analysis of iron-oxide nanoparticles10.1021/mp900161h ↗
28. Applications of the ninhydrin reaction for analysis of amino acids, peptides, and proteins to agricultural and biomedical sciences10.1021/jf030490p ↗
29. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice10.1172/JCI965 ↗
30. Development and characterization of magnetic cationic liposomes for targeting tumor microvasculature10.1016/j.bbamem.2006.10.006 ↗
31. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging10.1007/s003300100908 ↗
32. Negative preclinical results with stealth((r)) nanospheres-encapsulated doxorubicin in an orthotopic murine brain tumor model10.1016/j.jconrel.2004.07.019 ↗
33. Intra-arterial drug delivery: a concise review10.1097/ANA.0b013e318033da41 ↗
34. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors10.1002/(SICI)1097-0142(20000201)88:3<637::AID-CNCR22>3.0.CO;2-Y ↗
35. Vascular microenvironment in gliomas10.1023/A:1006474832189 ↗
36. Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres10.3109/10611869808997896 ↗
37. Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance10.1016/0006-2952(92)90443-M ↗
38. A polymer library approach to suicide gene therapy for cancer10.1073/pnas.0407218101 ↗